Overview

Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
Phase 1/2a Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinetic Study Comparing EG-1962 and Nimodipine in Patients with Aneurysmal Subarachnoid Hemorrhage
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Edge Therapeutics Inc
Treatments:
Nimodipine